Asserts that although no instrument has proved sufficiently robust to recommend universal screening, screening instruments for autism spectrum disorder (ASD) can play an important role. Discusses the clinical issues raised in screening for a developmental disorder, including risk status, management advice, and availability of services. Asserts that a by-product of screening is improvement in training and knowledge of health practitioners about early ASD signs. (Author/KB)